Treatment of allergic rhinitis can improve blood pressure control
Owing to high prevalence of arterial hypertension (AH) and allergic rhinitis (AR), these diseases frequently coexist. The study aimed to assess whether improvement of AR by conventional treatment can improve blood pressure (BP) control in this population. Sixty-eight subjects of both sexes aged 35–6...
Gespeichert in:
| Veröffentlicht in: | Journal of human hypertension 2006-11, Vol.20 (11), p.888-893 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 893 |
|---|---|
| container_issue | 11 |
| container_start_page | 888 |
| container_title | Journal of human hypertension |
| container_volume | 20 |
| creator | Magen, E Yosefy, C Viskoper, R J Mishal, J |
| description | Owing to high prevalence of arterial hypertension (AH) and allergic rhinitis (AR), these diseases frequently coexist. The study aimed to assess whether improvement of AR by conventional treatment can improve blood pressure (BP) control in this population. Sixty-eight subjects of both sexes aged 35–60 years with AR and AH were randomized into two groups to receive in addition to their antihypertensive medications: treatment group (
n
=34) Fluticasone nasal 50
μ
g/spray b.i.d. and Fenoxifenadine 180 mg tablets q.d., and control group (
n
=34) 0.9% NaCl nasal drops b.i.d. Office BP and AR severity (using the Relative Quality of Life Questionnaire (RQLQ)) and high-sensitive C-reactive protein (hs-CRP) were measured at study entry and after 8 weeks in both groups, without changing of antihypertensive medications. In Treatment group an improvement in RQLQ, significant reduction of systolic BP (SBP) (DSBP 7.4±4.3 mm Hg,
P
=0.006) and reduction of hs-CRP level (DCRP 2.05±1.08;
P
=0.028) were observed, whereas diastolic BP (DBP) remained unchanged (DDBP 0.9±1.7 mm Hg,
P
=0.7). There was a significant correlation between DRQLQ and DSBP (
r
=0.86;
P
=0.019) and between DCRP and DSBP (
r
=0.56;
P
=0.027). No statistically significant changes of RQLQ, BP and CRP were observed in the control group. In patients with coincidence of AH and AR, medications meant to improve AR attenuate low-grade systemic inflammation and can lower SBP, but not DBP. |
| doi_str_mv | 10.1038/sj.jhh.1002088 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_68985282</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A183336403</galeid><sourcerecordid>A183336403</sourcerecordid><originalsourceid>FETCH-LOGICAL-c578t-6b5f8a07e815c9a2e8319c34c6de8773cea0a36273da3c9b8394dcbada2460e33</originalsourceid><addsrcrecordid>eNp1kk1v1DAQhiMEotvClRsoAtFbtnbs-OO4qiggVeJSzpbjTDZeOfZiJ0j8exxtpC2olQ-2PM-8M57XRfEOoy1GRNykw_YwDPmMaiTEi2KDKWdV09T8ZbFBskGVrCm6KC5TOiC0BMXr4gIzyTiizabYPUTQ0wh-KkNfaucg7q0p42C9nWwqjfalHY8x_IaydSF05TFCSnOE0gQ_xeDeFK967RK8Xfer4ufdl4fbb9X9j6_fb3f3lWm4mCrWNr3QiIPAjZG6BkGwNIQa1oHgnBjQSBNWc9JpYmQriKSdaXWna8oQEHJVXJ90czO_ZkiTGm0y4Jz2EOakmJCiqUWdwU__gYcwR597UzWjiNUM04X6-CyFpeSMcnqW2msHyvo-TFGbpa7aYUEIyXpLZ9snqLw6GG2eEvQ23_-TcP0oYQDtpiEFN082-PSksokhpQi9OkY76vhHYaQW_1U6qOy_Wv3PCR_WV83tCN0ZXw3PwOcV0Mlo10ftjU1nTmBJsjGZuzlxKYf8HuJ5PM-Wfn_K8HrK3-NRp6f4X6_4zsU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>219976474</pqid></control><display><type>article</type><title>Treatment of allergic rhinitis can improve blood pressure control</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>EZB Electronic Journals Library</source><creator>Magen, E ; Yosefy, C ; Viskoper, R J ; Mishal, J</creator><creatorcontrib>Magen, E ; Yosefy, C ; Viskoper, R J ; Mishal, J</creatorcontrib><description>Owing to high prevalence of arterial hypertension (AH) and allergic rhinitis (AR), these diseases frequently coexist. The study aimed to assess whether improvement of AR by conventional treatment can improve blood pressure (BP) control in this population. Sixty-eight subjects of both sexes aged 35–60 years with AR and AH were randomized into two groups to receive in addition to their antihypertensive medications: treatment group (
n
=34) Fluticasone nasal 50
μ
g/spray b.i.d. and Fenoxifenadine 180 mg tablets q.d., and control group (
n
=34) 0.9% NaCl nasal drops b.i.d. Office BP and AR severity (using the Relative Quality of Life Questionnaire (RQLQ)) and high-sensitive C-reactive protein (hs-CRP) were measured at study entry and after 8 weeks in both groups, without changing of antihypertensive medications. In Treatment group an improvement in RQLQ, significant reduction of systolic BP (SBP) (DSBP 7.4±4.3 mm Hg,
P
=0.006) and reduction of hs-CRP level (DCRP 2.05±1.08;
P
=0.028) were observed, whereas diastolic BP (DBP) remained unchanged (DDBP 0.9±1.7 mm Hg,
P
=0.7). There was a significant correlation between DRQLQ and DSBP (
r
=0.86;
P
=0.019) and between DCRP and DSBP (
r
=0.56;
P
=0.027). No statistically significant changes of RQLQ, BP and CRP were observed in the control group. In patients with coincidence of AH and AR, medications meant to improve AR attenuate low-grade systemic inflammation and can lower SBP, but not DBP.</description><identifier>ISSN: 0950-9240</identifier><identifier>EISSN: 1476-5527</identifier><identifier>DOI: 10.1038/sj.jhh.1002088</identifier><identifier>PMID: 16967045</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Adult ; Allergic rhinitis ; Analysis of Variance ; Androstadienes - therapeutic use ; Anti-Allergic Agents - therapeutic use ; Antihypertensive agents ; Antihypertensive Agents - therapeutic use ; Antihypertensive drugs ; Antihypertensives ; Arterial hypertension. Arterial hypotension ; Biological and medical sciences ; Biomarkers - blood ; Blood and lymphatic vessels ; Blood pressure ; Blood Pressure - drug effects ; C-reactive protein ; C-Reactive Protein - drug effects ; C-Reactive Protein - metabolism ; Cardiology. Vascular system ; Cardiovascular system ; Care and treatment ; Clinical manifestations. Epidemiology. Investigative techniques. Etiology ; Diagnosis ; Dosage and administration ; Epidemiology ; Female ; Fluticasone ; Hay-fever ; Health Administration ; Humans ; Hypertension ; Hypertension - blood ; Hypertension - complications ; Hypertension - physiopathology ; Hypertension - prevention & control ; Male ; Medical sciences ; Medicine ; Medicine & Public Health ; Middle Aged ; original-article ; Pharmacology. Drug treatments ; Public Health ; Quality of Life ; Rhinitis ; Rhinitis, Allergic, Perennial - blood ; Rhinitis, Allergic, Perennial - complications ; Rhinitis, Allergic, Perennial - drug therapy ; Rhinitis, Allergic, Perennial - physiopathology ; Risk factors ; Severity of Illness Index ; Sodium chloride ; Sodium Chloride - administration & dosage ; Statistical analysis ; Surveys and Questionnaires ; Terfenadine - analogs & derivatives ; Terfenadine - therapeutic use ; Treatment Outcome</subject><ispartof>Journal of human hypertension, 2006-11, Vol.20 (11), p.888-893</ispartof><rights>Springer Nature Limited 2006</rights><rights>2006 INIST-CNRS</rights><rights>COPYRIGHT 2006 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Nov 2006</rights><rights>Nature Publishing Group 2006.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c578t-6b5f8a07e815c9a2e8319c34c6de8773cea0a36273da3c9b8394dcbada2460e33</citedby><cites>FETCH-LOGICAL-c578t-6b5f8a07e815c9a2e8319c34c6de8773cea0a36273da3c9b8394dcbada2460e33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/sj.jhh.1002088$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/sj.jhh.1002088$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18193319$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16967045$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Magen, E</creatorcontrib><creatorcontrib>Yosefy, C</creatorcontrib><creatorcontrib>Viskoper, R J</creatorcontrib><creatorcontrib>Mishal, J</creatorcontrib><title>Treatment of allergic rhinitis can improve blood pressure control</title><title>Journal of human hypertension</title><addtitle>J Hum Hypertens</addtitle><addtitle>J Hum Hypertens</addtitle><description>Owing to high prevalence of arterial hypertension (AH) and allergic rhinitis (AR), these diseases frequently coexist. The study aimed to assess whether improvement of AR by conventional treatment can improve blood pressure (BP) control in this population. Sixty-eight subjects of both sexes aged 35–60 years with AR and AH were randomized into two groups to receive in addition to their antihypertensive medications: treatment group (
n
=34) Fluticasone nasal 50
μ
g/spray b.i.d. and Fenoxifenadine 180 mg tablets q.d., and control group (
n
=34) 0.9% NaCl nasal drops b.i.d. Office BP and AR severity (using the Relative Quality of Life Questionnaire (RQLQ)) and high-sensitive C-reactive protein (hs-CRP) were measured at study entry and after 8 weeks in both groups, without changing of antihypertensive medications. In Treatment group an improvement in RQLQ, significant reduction of systolic BP (SBP) (DSBP 7.4±4.3 mm Hg,
P
=0.006) and reduction of hs-CRP level (DCRP 2.05±1.08;
P
=0.028) were observed, whereas diastolic BP (DBP) remained unchanged (DDBP 0.9±1.7 mm Hg,
P
=0.7). There was a significant correlation between DRQLQ and DSBP (
r
=0.86;
P
=0.019) and between DCRP and DSBP (
r
=0.56;
P
=0.027). No statistically significant changes of RQLQ, BP and CRP were observed in the control group. In patients with coincidence of AH and AR, medications meant to improve AR attenuate low-grade systemic inflammation and can lower SBP, but not DBP.</description><subject>Adult</subject><subject>Allergic rhinitis</subject><subject>Analysis of Variance</subject><subject>Androstadienes - therapeutic use</subject><subject>Anti-Allergic Agents - therapeutic use</subject><subject>Antihypertensive agents</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Antihypertensive drugs</subject><subject>Antihypertensives</subject><subject>Arterial hypertension. Arterial hypotension</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>Blood and lymphatic vessels</subject><subject>Blood pressure</subject><subject>Blood Pressure - drug effects</subject><subject>C-reactive protein</subject><subject>C-Reactive Protein - drug effects</subject><subject>C-Reactive Protein - metabolism</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular system</subject><subject>Care and treatment</subject><subject>Clinical manifestations. Epidemiology. Investigative techniques. Etiology</subject><subject>Diagnosis</subject><subject>Dosage and administration</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Fluticasone</subject><subject>Hay-fever</subject><subject>Health Administration</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypertension - blood</subject><subject>Hypertension - complications</subject><subject>Hypertension - physiopathology</subject><subject>Hypertension - prevention & control</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>original-article</subject><subject>Pharmacology. Drug treatments</subject><subject>Public Health</subject><subject>Quality of Life</subject><subject>Rhinitis</subject><subject>Rhinitis, Allergic, Perennial - blood</subject><subject>Rhinitis, Allergic, Perennial - complications</subject><subject>Rhinitis, Allergic, Perennial - drug therapy</subject><subject>Rhinitis, Allergic, Perennial - physiopathology</subject><subject>Risk factors</subject><subject>Severity of Illness Index</subject><subject>Sodium chloride</subject><subject>Sodium Chloride - administration & dosage</subject><subject>Statistical analysis</subject><subject>Surveys and Questionnaires</subject><subject>Terfenadine - analogs & derivatives</subject><subject>Terfenadine - therapeutic use</subject><subject>Treatment Outcome</subject><issn>0950-9240</issn><issn>1476-5527</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kk1v1DAQhiMEotvClRsoAtFbtnbs-OO4qiggVeJSzpbjTDZeOfZiJ0j8exxtpC2olQ-2PM-8M57XRfEOoy1GRNykw_YwDPmMaiTEi2KDKWdV09T8ZbFBskGVrCm6KC5TOiC0BMXr4gIzyTiizabYPUTQ0wh-KkNfaucg7q0p42C9nWwqjfalHY8x_IaydSF05TFCSnOE0gQ_xeDeFK967RK8Xfer4ufdl4fbb9X9j6_fb3f3lWm4mCrWNr3QiIPAjZG6BkGwNIQa1oHgnBjQSBNWc9JpYmQriKSdaXWna8oQEHJVXJ90czO_ZkiTGm0y4Jz2EOakmJCiqUWdwU__gYcwR597UzWjiNUM04X6-CyFpeSMcnqW2msHyvo-TFGbpa7aYUEIyXpLZ9snqLw6GG2eEvQ23_-TcP0oYQDtpiEFN082-PSksokhpQi9OkY76vhHYaQW_1U6qOy_Wv3PCR_WV83tCN0ZXw3PwOcV0Mlo10ftjU1nTmBJsjGZuzlxKYf8HuJ5PM-Wfn_K8HrK3-NRp6f4X6_4zsU</recordid><startdate>20061101</startdate><enddate>20061101</enddate><creator>Magen, E</creator><creator>Yosefy, C</creator><creator>Viskoper, R J</creator><creator>Mishal, J</creator><general>Nature Publishing Group UK</general><general>Nature Publishing</general><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20061101</creationdate><title>Treatment of allergic rhinitis can improve blood pressure control</title><author>Magen, E ; Yosefy, C ; Viskoper, R J ; Mishal, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c578t-6b5f8a07e815c9a2e8319c34c6de8773cea0a36273da3c9b8394dcbada2460e33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adult</topic><topic>Allergic rhinitis</topic><topic>Analysis of Variance</topic><topic>Androstadienes - therapeutic use</topic><topic>Anti-Allergic Agents - therapeutic use</topic><topic>Antihypertensive agents</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Antihypertensive drugs</topic><topic>Antihypertensives</topic><topic>Arterial hypertension. Arterial hypotension</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>Blood and lymphatic vessels</topic><topic>Blood pressure</topic><topic>Blood Pressure - drug effects</topic><topic>C-reactive protein</topic><topic>C-Reactive Protein - drug effects</topic><topic>C-Reactive Protein - metabolism</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular system</topic><topic>Care and treatment</topic><topic>Clinical manifestations. Epidemiology. Investigative techniques. Etiology</topic><topic>Diagnosis</topic><topic>Dosage and administration</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Fluticasone</topic><topic>Hay-fever</topic><topic>Health Administration</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypertension - blood</topic><topic>Hypertension - complications</topic><topic>Hypertension - physiopathology</topic><topic>Hypertension - prevention & control</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>original-article</topic><topic>Pharmacology. Drug treatments</topic><topic>Public Health</topic><topic>Quality of Life</topic><topic>Rhinitis</topic><topic>Rhinitis, Allergic, Perennial - blood</topic><topic>Rhinitis, Allergic, Perennial - complications</topic><topic>Rhinitis, Allergic, Perennial - drug therapy</topic><topic>Rhinitis, Allergic, Perennial - physiopathology</topic><topic>Risk factors</topic><topic>Severity of Illness Index</topic><topic>Sodium chloride</topic><topic>Sodium Chloride - administration & dosage</topic><topic>Statistical analysis</topic><topic>Surveys and Questionnaires</topic><topic>Terfenadine - analogs & derivatives</topic><topic>Terfenadine - therapeutic use</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Magen, E</creatorcontrib><creatorcontrib>Yosefy, C</creatorcontrib><creatorcontrib>Viskoper, R J</creatorcontrib><creatorcontrib>Mishal, J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of human hypertension</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Magen, E</au><au>Yosefy, C</au><au>Viskoper, R J</au><au>Mishal, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of allergic rhinitis can improve blood pressure control</atitle><jtitle>Journal of human hypertension</jtitle><stitle>J Hum Hypertens</stitle><addtitle>J Hum Hypertens</addtitle><date>2006-11-01</date><risdate>2006</risdate><volume>20</volume><issue>11</issue><spage>888</spage><epage>893</epage><pages>888-893</pages><issn>0950-9240</issn><eissn>1476-5527</eissn><abstract>Owing to high prevalence of arterial hypertension (AH) and allergic rhinitis (AR), these diseases frequently coexist. The study aimed to assess whether improvement of AR by conventional treatment can improve blood pressure (BP) control in this population. Sixty-eight subjects of both sexes aged 35–60 years with AR and AH were randomized into two groups to receive in addition to their antihypertensive medications: treatment group (
n
=34) Fluticasone nasal 50
μ
g/spray b.i.d. and Fenoxifenadine 180 mg tablets q.d., and control group (
n
=34) 0.9% NaCl nasal drops b.i.d. Office BP and AR severity (using the Relative Quality of Life Questionnaire (RQLQ)) and high-sensitive C-reactive protein (hs-CRP) were measured at study entry and after 8 weeks in both groups, without changing of antihypertensive medications. In Treatment group an improvement in RQLQ, significant reduction of systolic BP (SBP) (DSBP 7.4±4.3 mm Hg,
P
=0.006) and reduction of hs-CRP level (DCRP 2.05±1.08;
P
=0.028) were observed, whereas diastolic BP (DBP) remained unchanged (DDBP 0.9±1.7 mm Hg,
P
=0.7). There was a significant correlation between DRQLQ and DSBP (
r
=0.86;
P
=0.019) and between DCRP and DSBP (
r
=0.56;
P
=0.027). No statistically significant changes of RQLQ, BP and CRP were observed in the control group. In patients with coincidence of AH and AR, medications meant to improve AR attenuate low-grade systemic inflammation and can lower SBP, but not DBP.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>16967045</pmid><doi>10.1038/sj.jhh.1002088</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0950-9240 |
| ispartof | Journal of human hypertension, 2006-11, Vol.20 (11), p.888-893 |
| issn | 0950-9240 1476-5527 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68985282 |
| source | MEDLINE; Springer Nature - Complete Springer Journals; EZB Electronic Journals Library |
| subjects | Adult Allergic rhinitis Analysis of Variance Androstadienes - therapeutic use Anti-Allergic Agents - therapeutic use Antihypertensive agents Antihypertensive Agents - therapeutic use Antihypertensive drugs Antihypertensives Arterial hypertension. Arterial hypotension Biological and medical sciences Biomarkers - blood Blood and lymphatic vessels Blood pressure Blood Pressure - drug effects C-reactive protein C-Reactive Protein - drug effects C-Reactive Protein - metabolism Cardiology. Vascular system Cardiovascular system Care and treatment Clinical manifestations. Epidemiology. Investigative techniques. Etiology Diagnosis Dosage and administration Epidemiology Female Fluticasone Hay-fever Health Administration Humans Hypertension Hypertension - blood Hypertension - complications Hypertension - physiopathology Hypertension - prevention & control Male Medical sciences Medicine Medicine & Public Health Middle Aged original-article Pharmacology. Drug treatments Public Health Quality of Life Rhinitis Rhinitis, Allergic, Perennial - blood Rhinitis, Allergic, Perennial - complications Rhinitis, Allergic, Perennial - drug therapy Rhinitis, Allergic, Perennial - physiopathology Risk factors Severity of Illness Index Sodium chloride Sodium Chloride - administration & dosage Statistical analysis Surveys and Questionnaires Terfenadine - analogs & derivatives Terfenadine - therapeutic use Treatment Outcome |
| title | Treatment of allergic rhinitis can improve blood pressure control |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T15%3A36%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20allergic%20rhinitis%20can%20improve%20blood%20pressure%20control&rft.jtitle=Journal%20of%20human%20hypertension&rft.au=Magen,%20E&rft.date=2006-11-01&rft.volume=20&rft.issue=11&rft.spage=888&rft.epage=893&rft.pages=888-893&rft.issn=0950-9240&rft.eissn=1476-5527&rft_id=info:doi/10.1038/sj.jhh.1002088&rft_dat=%3Cgale_proqu%3EA183336403%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=219976474&rft_id=info:pmid/16967045&rft_galeid=A183336403&rfr_iscdi=true |